3-methoxytyramine has been researched along with Substance Withdrawal Syndrome in 2 studies
3-methoxytyramine: RN given refers to parent cpd
3-methoxytyramine : A monomethoxybenzene that is dopamine in which the hydroxy group at position 3 is replaced by a methoxy group. It is a metabolite of the neurotransmitter dopamine and considered a potential biomarker of pheochromocytomas and paragangliomas.
Substance Withdrawal Syndrome: Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karoum, F | 1 |
| Egan, MF | 1 |
| Wyatt, RJ | 1 |
| Ahtee, L | 1 |
| Attila, LM | 1 |
| Carlson, KR | 1 |
| Haikala, H | 1 |
2 other studies available for 3-methoxytyramine and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Selective reduction in dopamine turnover in the rat frontal cortex and hypothalamus during withdrawal from repeated cocaine exposure.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Cocaine; Dopamine; Hypothalamus; Male; Prefrontal Cortex; R | 1994 |
Changes in brain monoamine metabolism during withdrawal from chronic oral self-administration of morphine and in response to a morphine challenge in the withdrawn state.
Topics: 3,4-Dihydroxyphenylacetic Acid; Administration, Oral; Animals; Biogenic Amines; Brain; Dopamine; Hyd | 1989 |